Page being updated

Diamond Sponsor

American Hospital Dubai is an internationally accredited general medical-surgical hospital providing patient-centric healthcare and customer services across a wide range of clinical areas.

The 254-bed hospital campus is equipped with the most advanced imaging and diagnostic technology and treatments, with a multidisciplinary team of physicians who are either USA-board certified or Western equivalent.

The American Hospital Dubai is also the first hospital in the Middle East to be awarded Joint Commission International (JCI) accreditation. Its laboratory is the first private lab to earn accreditation from the College of American Pathologists (CAP).

The Cancer Care Center is the first comprehensive facility to offer a range of Medical Oncology and Hematology services for all forms of cancers and blood disorders--in addition to traditional cancer treatment options of Surgery, Chemotherapy, Radiation Therapy, Palliative care and new therapies.

The Heart & Vascular Center now includes a range of vascular services and an updated state of the art angiosuite. The center is able to diagnose, monitor and treat all types of heart conditions through invasive and non-invasive cardiology procedures, cardiothoracic surgery, and vascular surgery, supported by advanced rehabilitation services.

Platinum Sponsors

Delivering a Unique Service to Oncology Patients in the UAE

Mediclinic City Hospital's Comprehensive Cancer Centre (CCC), which opened in the new North Wing extension in September 2016, is the UAE’s most advanced facility for the diagnosis and treatment of cancer. It provides a range of facilities and services, supported by the latest generation of equipment, some of which are entirely new not only to the UAE but to the entire MENA region.

Built in collaboration with Mediclinic Middle East’s sister platform in Switzerland, Hirslanden, patients at the CCC can, for the first time in the UAE, benefit from the sharing of knowledge and experience between some of the leading oncology experts in Europe and the Middle East, as well as access to the very latest treatment programmes and technology.

The CCC combines diagnostic procedures with the treatment modalities of surgery, medical oncology and radiation therapy, all under one roof. The value of the service provided by the CCC stems from the quality of the technology and equipment it houses. The CCC offers radiation therapy using the first TrueBeam linear accelerator in the UAE, and the only Varian 13.7 version in the MENA region, using the newest treatment technology of flattening filter free energy.


Bristol-Myers Squibb is a global BioPharma company firmly focused on its mission to discover, develop and deliver innovative medicines that help patients prevail over serious diseases.

Around the world, our medicines help millions of people in their fight against such diseases as cancer, cardiovascular disease, hepatitis B, Hepatitis C, HIV/AIDS, rheumatoid arthritis and psychiatric disorders.

At Bristol-Myers Squibb, our BioPharma strategy uniquely combines the reach and resources of a major pharma company with the entrepreneurial spirit and agility of a successful biotech company. With this strategy, we focus on our customers’ needs, giving maximum priority to accelerating pipeline development, delivering sales growth and continuing to manage costs.

Gold Sponsors

Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patient's lives through the discovery and commercialization of transformative tests to assess a person’s risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety and value in the discovery, development and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products.

Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time.

Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments and local communities to support and expand access to reliable, affordable health care around the world. For more than 150 years, Pfizer has worked to make a difference for all who rely on us.

Astellas is a global pharmaceutical company dedicated to changing tomorrow by improving people’s health through developing reliable first-in-line and best-in-class therapy options in our specialization areas – Oncology, Urology, Transplantation, Anti-Infectives and Pain management. Aiming to improve the lives of cancer patients we are focusing our R&D and partnership efforts into precision medicine - more than 12 separate innovative therapies are under clinical development targeting prostate cancer and other solid tumors like breast cancer, lung cancer, and bladder cancer, as well as hematological malignancies.

Silver Sponsors

Page Being Updated

Page Being Updated


Founded in Darmstadt, Germany in 1668 by Friedrich Jacob Merck, we are the world's oldest pharmaceutical and chemical company. Today, the Merck family remains the majority owner of the company.

Over the course of nearly 350 years, we have become a truly global company. Our approximately 50,000 employees work in 66 countries and are united by their passion for new ideas, the possibilities of technology, and the potential to make a difference in the world.

We are known as Merck internationally. In the United States and Canada, however, we operate as EMD Serono in the Biopharma business, as MilliporeSigma in the Life Science business, and as EMD Performance Materials in the materials business.


We help to create, improve and prolong life - continuously working to make a lasting difference in patients' lives.

Our portfolio includes medicines to treat cancer, multiple sclerosis, infertility, growth disorders, cardiovascular diseases, diabetes, and thyroid disorders.

We design and develop intelligent devices that provide ongoing care for patients beyond their treatment.

Our injection device and disease monitoring software make it possible for patients with multiple sclerosis to self-inject their medicine and monitor its administration. As a result, we help to make better use of their time with their neurologist.

We are leading the way in personalized medicine. With cancer, this precise approach uses biomarkers that match effective treatment to individual patients, predicting how the disease will progress and how they will respond to a treatment.

We support people at every stage of life - also when it comes to creating new life. Estimates show that we have helped bring more than two million babies into the world. As the global market leader in fertility treatments, we do what we do with passion – and we think further ahead. We have complemented our portfolio by fertility technologies, aiming to further increase the possibility of in vitro fertilization (IVF) success.

Support Sponsors

Page Being Updated


Myriad Genetics is a leading molecular diagnostic company dedicated to making a difference in patient's lives through the discovery and commercialization of transformative tests to assess a person’s risk of developing disease, guide treatment decisions and assess risk of disease progression and recurrence.

Helixor Heilmittel GmbH is an international company in the field of integrative oncology. Our Mission: improving the quality of life of cancer patients.
The company’s headquarter is in Rosenfeld, south of Stuttgart, Germany.
Helixor is active internationally with affiliates in Canada, Brazil and, most recently, India, and also works with distribution partners and customers in over 20 countries around the world.
Helixor medicinal products are produced in a unique manufacturing process in line with GMP regulations. Continuous clinical and preclinical research, as well as cooperation with university hospitals, physicians and scientists, demonstrate the efficacy and safety of our products.

Sirtex Medical is actively engaged in the field of liver-directed therapies for cancer patients. Our innovative technology, SIR-Spheres® Y-90 resin microspheres (microscopic Yttrium-90 resin beads), are approved for use in several countries for the treatment of unresectable liver tumours. In the US, SIR-Spheres Y-90 resin microspheres have a Pre-Market Approval (PMA) from the FDA and are indicated for the treatment of unresectable metastatic liver tumors from primary colorectal cancer with adjuvant intra-hepatic artery chemotherapy of Floxuridine.

SIR-Spheres® Y-90 resin microspheres are presently used at over 1000 institutions worldwide. To date, more than 70,000 treatments have been delivered globally.

®SIR-Spheres is a registered trademark of Sirtex SIR-Spheres Pty Ltd

Vitane Pharma GmbH

  • Vitane Pharma GmbH is a global pharmaceutical company harnessing its growth in region like Middle East , Africa , Europe & Asia .
  • The company is headquartered at Germany with affiliate offices in USA , United Arab Emirates, United Kingdom , Egypt , Nigeria & Russia.
  • Vitane products are manufactured at world class manufacturing facilities in Germany & USA.
  • Vitane has wide range of nutraceutical, pharmaceutical , Oncology & medical device where it addresses different therapeutic areas.

LEO Pharma

Founded in 1908, LEO Pharma is an independent, research-based pharmaceutical company that develops, manufactures and markets pharmaceutical drugs to dermatologic and thrombotic patients. LEO Pharma is headquartered in Ballerup, Denmark, and is represented in more than 100 countries worldwide.
LEO Pharma's goal is to improve the quality of life for people with skin conditions and those in need of critical care.
In dermatology, LEO Pharma's vision is to become the preferred dermatology care partner improving people’s lives around the world by focusing on drugs and therapies for the treatment of psoriasis, eczema, acne and skin infections – conditions that can cause serious physical and social discomfort for millions of patients around the world.
In addition to dermatology; LEO Pharma has been developing heparin-based products since the 1940s with more than 70 years of experience in helping healthcare professionals and patients all over the world to prevent and treat potentially life-threatening and disabling conditions such as Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE).
LEO Pharma also has a range of well-established products in the areas of cardiovascular, antibiotics, coagulation, osteoporosis and renal care.


Cryogene is a privately owned Lebanon-based company founded in 2004, whose scope of activity is mainly specialized medical services.

Cryogene is offering Tumor Profiling by "OncoDna" in Belgium. Cryogene has been representing “OncoDna” in the Middle East since 2014.

Cryogene is the sole distributor of Mammaprint by "Agendia", a commonly used genomic test for risk stratification of breast cancer.

Cryogene is pursuing its involvement in genetic, providing genetic testing for different medical specialties. Those analysis are performed in accredited laboratories in Europe and USA.

Cryogene is now running several offices in the Middle East, Cyprus and Turkey.

Integrated Gulf Biosystems (IGB)

Integrated Gulf Biosystems (IGB) is a partner of choice for Life Science & Clinical genomic solutions in the Middle East (KSA, UAE, Qatar, and Bahrain). We differentiate ourselves through exemplary sales, service and application support. We are channel partners for Thermofisher Scientific, Hamilton (Robotics and Storage), Molecular Devices and several others.

For Cancer research, our portfolio includes Cell imaging systems, NGS cancer panels, Real-time PCR assays and cell culture reagents. We also offer a large collection of antibodies for flow cytometry and protein analysis.


BIOLOGIX FZCO, part of a Pharmaceutical Manufacturers group established in Lebanon, it started in 1997 as a division of Algorithm a Lebanese Pharmaceuticals Manufacturer, then was registered in September 2002 to operate under the laws of the UAE as a logistic hub in Dubai. BIOLOGIX distributes and promotes Pharmaceutical Specialties and Biotechnology products for Biogen Idec, Lilly, Acino, Celgene, Ipsen, Shire and Gentium in the Near East, Gulf region, North Africa, and Iran through regional agreements with a right to appoint local sub-distributors.

BIOLOGIX ensures receipt, storage and dispatching of goods to customers in the MENA region with knowledge of specific market requirements. Its closeness to markets allows quick response to market needs and alerts. By providing a complete infrastructure for its operations in Dubai (cold rooms, freezing room, back-up generator, monitoring system, information system), it represents a “one stop shop” to licensors and purchasing bodies for logistics and regulatory affairs. BIOLOGIX offers also complete marketing and sales services with well trained sales structure and total and early alignment of marketing messages.

BIOLOGIX is audited by the local authorities and is an approved site of supply. It operates under GDP guidelines.

Page being updated

For Sponsorship and Exhibition inquiries, please contact